Overall Survival Following Neoadjuvant Chemotherapy Versus Adjuvant Chemotherapy in Clinically Node Negative T1 Triple Negative Breast Cancer

Kai Huang, James Jakub, Emmanuel Gabriel, Alvaro Moreno-Aspitia, Sarah McLaughlin

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Overall Survival Following Neoadjuvant Chemotherapy Versus Adjuvant Chemotherapy in Clinically Node Negative T1 Triple Negative Breast Cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences